Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
May 26, 2020

Ortho completes PHE evaluation for IgG Covid-19 test

By Chloe Kent

Ortho Clinical Diagnostics’ IgG Covid-19 antibody test has completed evaluation with Public Health England (PHE).

The test is hoped to be deployed as part of back-to-work strategies and in serological surveys to understand infection rates and immune responses throughout the population. It offers 100% specificity and runs on Ortho’s high-throughput, fully automated analysers including its flagship VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System and the VITROS 5600 Integrated System.

The test was CE marked on 18 May. Ortho previously announced the CE marking of its total antibody test, which detects the IgA and IgM alongside the IgG Covid-19 antibodies. These appear earlier in the infection, and can help determine the onset of a patient’s immune response.

Ortho is now collaborating with the UK Department of Health and Social Care to assess how to deploy the tests throughout the country

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU